Mitochondrial electron transport chain Coenzyme Q10 quinone sites (Q-sites)

The mitochondrial electron transport chain (ETC) Coenzyme Q10 (CoQ10) quinone sites, commonly referred to as Q-sites, are critical functional pockets within respiratory complexes I, II, and III. These sites facilitate the binding and redox cycling of CoQ10 (ubiquinone), a lipophilic electron carrier that shuttles electrons from Complexes I and II to Complex III. By mediating these transfers, the Q-sites are essential for maintaining the proton motive force required for ATP synthesis and for regulating the production of reactive oxygen species (ROS). In therapeutic contexts, these sites are targeted by a variety of drugs to modulate mitochondrial function. For instance, atovaquone acts as a competitive inhibitor at the Q-sites of Complex III to treat parasitic infections like malaria and is being explored for its anti-tumor properties in cancer. Conversely, CoQ10 supplementation is used to bypass or mitigate deficiencies in these pathways, particularly in primary CoQ10 deficiency and age-related mitochondrial decline.

Other names

Q-sitesUbiquinone binding sitesCoQ binding sitesQuinone reduction sitesComplex I Q-siteComplex II Q-siteComplex III Q-sitesQi siteQo site

Drugs targeting these sites typically act through competitive inhibition of Coenzyme Q10 binding, which blocks the transfer of electrons through the respiratory chain. This disruption halts the establishment of the proton gradient, thereby inhibiting ATP synthesis and often triggering the overproduction of reactive oxygen species (ROS), leading to oxidative stress and potential cell death in target organisms or cells.